Dynavax Awarded NIH Grant To Explore Feasibility Of Universal Papilloma Virus Vaccine
Links shared publicly online about this topic.
- 1,039total visits
Dynavax Awarded NIH Grant To Explore Feasibility Of Universal Papilloma Virus Vaccine
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the award of a $600,000 grant from the National Institutes of Health (NIH) to explore the feasibility of developing a universal vacc
View full resource at medicalnewstoday.com
Tags: Vaccination, Wart, STD, HPV, National Institutes of Health, Vaccine
Most Recently Shared on July 8, 2010 at 10:40 am By:
Dynavax Awarded NIH Grant To Explore Feasibility Of Universal Papilloma Virus Vaccine: Dynavax Technologies Corpor... http://mnt.to/f/3FPF
Also Shared By:
Advertisement
MNT Cervical Cancer
@mnt_cervical
Dynavax Awarded NIH Grant To Explore Feasibility Of Universal Papilloma Virus Vaccine http://mnt.to/3FPF #cervicalcancer #hpv
1 year ago...